Stevia rebaudiana (Bertoni) Bertoni, Asteraceae, is a plant with hypoglycemic and antihyperlipidemic properties. S. rebaudiana (SrB) has become a lead candidate for the treatment of the diabetes mellitus. However, chronic administrations of S. rebaudiana are required to cause the normoglycemic effect. Importantly, nanomaterials in general and titanium dioxide (TiO2) in particular have become effective tools for drug delivery. In this work, we obtained TiO2 nanomaterials with SrB at different concentrations (10, 20 and 30 μM) by sol–gel method. After this nanomaterials were characterized by Fourier transform infrared spectroscopy and transmission electron microscopy. Where it was demonstrated, the presence of the S. rebaudiana in TiO2 nanomaterials, which were observed as hemispherical agglomerated particles of different sizes. The nanomaterials were evaluated in male rats whose diabetes mellitusphenotype was induced by alloxan (200 mg/kg, i.p.). The co-administration of TiO2-SrB (20 and 30 μM) induced a significant and permanent decrease in the glucose concentration since 4 h, until 30 days post-administration. Likewise, the concentrations of insulin, glycosylated hemoglobin, cholesterol, and triacylglycerides showed a significant recovery to basal levels. The major finding of the study was that the TiO2-SrB (20 and 30 μM) has a potent and prolonged activity antidiabetic. TiO2 can be considered like an appropriated vehicle in the continuous freeing of active substances to treat of diabetes mellitus.
Barb, C., Bartlett, J., Kong, L., 2004. Silica particles: a novel drug-delivery system. Adv. Mater. 16, 1959–1966.
Chan, P., Xu, D.Y., Liu, J.C., Chen, Y.J., Tomlinson, B., Huang, W.P., 1998. The effect of stevioside on blood pressure and plasma catecholamines in spontaneously hypertensive rats. Life Sci. 63, 1679–1684.
Chen, T.H., Chen, S.C., Chan, P., Chu, Y.L., Yang, H.Y., Cheng, J.T., 2005. Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana. Planta Med. 71, 108–113.
Curry, L.L., Roberts, A., 2008. Subchronic toxicity of rebaudioside A. Food Chem. Toxicol. 46, 11–20.
Himanshu, M., Manish, S., Narendra, S., Darshana, M., Mehta, B., Jain, D.C., 2011. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan induced diabetic rats. J. Pharm. Bioallied. Sci. 3, 242–248.
Jeppesen, P.B., Gregersen, S., Poulsen, C.R., Hermansen, K., 2000. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism 49, 208–214.
Laitiff, A.A., Teoh, S.L., Das, S., 2010. Wound healing in diabetes mellitus: traditional treatment modalities. Clin. Ter. 161, 359–364.
López, T.D., Francos, M.A., González, A.F., Díaz-García, M.E., Badía-Laíño, R., 2015. Controlled release of nafcillin using biocompatible “Dummy” molecularly imprinted sol–gel nanospheres. Curr. Top. Med. Chem. 15, 262–270.
López, T., Bata-García, J.L., Esquivel, D., Ortiz-Islas, E., González, R., Ascencio, J., Quintana, P., Oskam, G., Álvarez-Cervera, F.J., Heredia-López, F.J., Góngora-Alfaro, J.L., 2010. Treatment of Parkinson’s disease: nanostructured sol–gel silicadopamine reservoirs for controlled drug release in the central nervous system. Int. J. Nanomed. 6, 19–31.
López, T., Ortiz, E., Álvarez, M., Navarrete, J., Odriozola, J.A., Martínez-Ortega, F., Páez-Mozo, E.A., Escobar, P., Espinoza, K.A., Rivero, I.A., 2010. Study of the stabilization of zinc phthalocyanine in sol–gel TiO2 for photodynamic therapy applications. Nanomedicine 6, 777–785.
Malviya, N., Jain, S., Malviya, S., 2010. Antidiabetic potential of medicinal plants. Acta Pol. Pharm. 67, 113–118.
Misra, H., Soni, M., Silawat, N., Mehta, D., Mehta, B.K., Jain, D.C., 2011. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats. J. Pharm. Bioallied Sci. 3 (2), 242–248.
Park, J.E., Cha, Y.S., 2010. Stevia rebaudiana Bertoni extract supplementation improves lipid and carnitine profiles in C57BL/6J mice fed a high-fat diet. J. Sci. Food Agric. 90, 1099–10105.
Raskovic, A., Gavrilovic, M., Jakovljevic, V., Sabo, J., 2004. Glucose concentration in the blood of intact and alloxan-treated mice after pretreatment with commercial preparations of Stevia rebaudiana (Bertoni). Eur. J. Drug Metab. Pharmacokinet. 29, 87–90.
Shivanna, N., Naika, M., Khanum, F., Kaul, V.K., 2013. Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana. J. Diabetes Complications 27, 103–113.
Soejarto, D.D., Kinghorn, A.D., Farnsworth, N.R., 1982. Potential sweetening agent of plant origin III: organoleptic evaluation of Stevia leaf herbarium samples for sweetness. J. Nat. Prod. 45, 590–599.
Son, S.J., Bai, X., Lee, S.B., 2007. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. Drug Discovery Today 12, 650–656.
Starratt, A.N., Kirby, C.W., Pocs, R., Brandle, J.E., Rebaudioside, F., 2002. A diterpene glycoside from Stevia rebaudiana. Phytochemistry 59, 367–370.
Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B-cells of the rat pancreas. Physiol. Res. 50, 537–546.
The authors thank Dr. Carlos Escamilla for his help with the animal care and thanks to Thomas Edwards, PhD for editing the English language text.
The authors declare no conflicts of interest.
About this article
Cite this article
Langle, A., González-Coronel, M.A., Carmona-Gutiérrez, G. et al. Stevia rebaudiana loaded titanium oxide nanomaterials as an antidiabetic agent in rats. Rev. Bras. Farmacogn. 25, 145–151 (2015). https://doi.org/10.1016/j.bjp.2015.03.004
- Stevia rebaudiana